Master the R Series Bootcamp Registration is Open.

Science Funding In The FY11 Budget (NIH, NSF, CDC, FDA, NIST, DOE)

By Bouvier Grant Group

We stay current on NIH happenings and would be delighted to keep you informed.

We now know that NIH will receive $30.7B for FY11. While this funding level is hardly a dream scenario for research scientists, given the current economic situation we are all heaving a collective sigh of relief (for now.) Once you have wiped the sweat from your brow, your next thought may be to wonder how other science agencies fared in FY11.

Like NIH, other science agencies were spared deep cuts for the time being. Jennifer Zeitzer, director of legislative relations for Federation of American Societies for Experimental Biology, is quoted as saying, “Considering the overall level of cuts, the impact of the federal science agencies of interest to FASEB was fairly minimal.” How minimal? Here are the numbers:

NSF $6.9B for FY11 ($53M less than FY10, $551 less than the Administration’s recommendation for FY11, $307M above the House recommendation.)

CDC $5.66B for FY11 ($730M below FY10, $681M above the House recommendation.)

FDA $2.452B for FY11 (4% above FY10, 14% above the House recommendation.)

NIST $752M for FY11 ($55M higher than the level proposed by the House)

Department of Energy’s Office of Science $4.88B for FY11 (up $866M over the House level.)

DHHS agencies must submit spending details within 30 days of the enactment of an appropriation bill (NSF within 60 days), so we will know within the next month or two how the agencies will apportion the FY11 monies for the remaining six months of the federal year.

Author:
Dr. Meg Bouvier

Margaret Bouvier received her PhD in 1995 in Biomedical Sciences from the Mount Sinai School of Medicine. After an NINDS post-doctoral fellowship, she worked as a staff writer for long-standing NIH Director Dr. Francis Collins in the Office of Press, Policy, and Communications for the Human Genome Project and NHGRI. Since 2007, Meg has specialized in editing and advising on NIH submissions, and began offering virtual courses in 2015. She's recently worked with more than 40% of the nation's highest-performing hospitals*, four of the top 10 cancer hospitals, three of the top five medical schools for research, and 14 NCI-designated cancer centers. Her experience at NIH as both a bench scientist and staff writer greatly informs her approach to NIH grantwriting. She has helped clients land over half a billion in federal funding. Bouvier Grant Group is a woman-owned small business.

*Our clients include 9 of the top 22 hospitals as recognized by the 2023/24 US News & World Report honor roll

Categories:
We read all NIH notices for our clients. When you join our mailing list, we’ll pass along important changes directly to your inbox, as well as opportunities to improve your grantsmanship skills.
Primary Position
Lead Source

Wait!

Subscribe to our monthly newsletter for the latest NIH news, grantwriting tips, and more.

NIH-October-2023-Newsletter